What You Need to Know About Hinge Health, Inc.'s Q4 Earnings
Hinge Health, Inc.'s fiscal Q4 earnings report was released on Monday, November 02. Let's dive in to see if (HNGE) missed or beat analyst's expectations.Jenna Brashear
Stock Evaluator: Hinge Health, Inc. (HNGE)
Hinge Health, Inc. HNGE
$115.76
-0.22
-0.19%
November 6, 2026 4:00:02 PM
EST
Volume: 1,540,173
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Commentary & Analysis
Why Hinge Health, Inc.’s (HNGE) Stock Is Up 5.21%
As of Monday, September 14, Hinge Health, Inc.’s HNGE share price has surged by 5.21%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Hinge Health, Inc.’s (HNGE) Stock Is Up 7.23%
As of Friday, August 07, Hinge Health, Inc.’s HNGE share price has surged by 7.23%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Hinge Health, Inc.’s (HNGE) Stock Is Up 10.29%
As of Friday, August 07, Hinge Health, Inc.’s HNGE share price has surged by 10.29%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Hinge Health, Inc.’s (HNGE) Stock Is Up 10.65%
As of Wednesday, August 05, Hinge Health, Inc.’s HNGE share price has surged by 10.65%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | HNGE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $9,341.2 | $1,904.5 | 77% |
|
| Shares Out (Mil) | 83.4 | 79.2 | 58% |
|
| Institutional Ownership | 82.8% | 86.0% | 51% |
|
| Float (Mil) | 50.6 | 58.8 | 47% |
|
| Beta | na | 0.75 | na |
|
| Avg Daily Volume (000s) | 2,171 | 722 | 81% |
|
| Price Change (52-week) |
155.0% | 82.2% | 98% |
|
| Growth | HNGE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.3% | na |
|
| Net Income (5yr) | na | (0.7%) | na |
|
| EPS (5yr) | na | 2.1% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.4%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 13 | 14 | 14 | |
| Current EPS | $0.735 | $2.573 | $3.256 | |
| Month Ago EPS | $0.660 | $2.399 | $3.057 | |
| # Rev Up | 3 | 4 | 2 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.687 | $2.441 | $3.154 | |
| Year/Year Chg | 41.3% | (133.1%) | (156.1%) | |
| Financials | HNGE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $720 | $1,505 | 45% |
|
| Net Income (TTM) (Mil) | $109 | $32 | 61% |
|
| EPS (TTM) | $1.360 | $0.300 | 64% |
|
| Operating Cash Flow (TTM) (Mil) | $291 | $160 | 63% |
|
| Net Cash Flow (TTM) (Mil) | $49 | $2 | 70% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $421 | 19% |
|
| Enterprise Value (Q1) (Mil) | $5,954 | $2,459 | 66% |
|
| Valuation | HNGE | Industry Median |
Percentile (All Stocks) |
|
| P/B | 26.98 | 2.84 | 97% |
|
| P/E | 86.7 | 27.1 | 93% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | HNGE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 85.8% | 27.9% | 92% |
|
| Net Margin | 21.0% | 1.4% | 79% |
|
| ROA | 14.3% | 2.2% | 92% |
|
| ROE | 42.1% | 6.9% | 91% |
|
| Liabilities to Assets | 58.4% | 61.2% | 52% |
|
| F-Score | 4 | 5 | 33% |
|
Passing Stock Screens
As of 11/6/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Est Rev: Top 30 Up
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 21.3% |
| +/- S&P 500: | +13.9 |
FACTOR STRATEGY
Est Rev: Up 5% Screen
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 22.2% |
| +/- S&P 500: | +14.8 |
